Robert Burns Score: 27
Analyst at
H.C. Wainwright
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+444.2%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
39%
22 W / 35 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
55%
21 W / 17 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
13%
5 W / 33 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
3%
1 W / 37 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
35%
17 W / 32 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
38%
20 W / 33 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
50%
2 W / 2 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Oct 22, 2026 |
Parabilis Medicines, Inc.
PBLS
|
BUY |
$40.00
Est. +44%
|
$27.85 | $30.83 |
Pending
|
$30.36
+9.0%
|
| Oct 08, 2026 |
ArriVent BioPharma Inc.
AVBP
|
BUY |
$27.00
Est. +60%
|
$16.89 | $21.22 |
Pending
|
$13.49
-20.1%
|
| Sep 21, 2026 |
Adicet Bio Inc
ACET
|
BUY |
$27.00
Est. +194%
|
$9.18 | $9.39 |
Pending
|
$3.10
-66.2%
|
| Sep 01, 2026 |
BlossomHill Therapeutics, Inc.
BLSM
|
BUY |
$35.00
Est. +91%
|
$18.30 | $18.22 |
Pending
|
$12.38
-32.3%
|
| Aug 27, 2026 |
Revolution Medicines Inc
RVMD
|
BUY |
$280.00
Est. +30%
|
$215.44 | $224.31 |
Pending
|
$199.70
-7.3%
|
| Aug 18, 2026 |
Tango Therapeutics Inc
TNGX
|
BUY |
$68.00
Est. +169%
|
$25.29 | $27.97 |
Pending
|
$23.18
-8.3%
|
| Aug 10, 2026 |
ORIC Pharmaceuticals Inc
ORIC
|
BUY |
$27.00
Est. +100%
|
$13.50 | $14.52 |
Pending
|
$9.34
-30.8%
|
| Aug 10, 2026 |
Immix Biopharma Inc
IMMX
|
BUY |
$25.00
Est. +157%
|
$9.72 | $15.10 |
Pending
|
$7.97
-18.0%
|
| Jul 31, 2026 |
Karyopharm Therapeutics Inc
KPTI
|
SELL |
$3.00
Est. +57%
|
$7.01 | $0.08 (Low) |
Target Met
|
$0.08
+98.8%
|
| Jul 09, 2026 |
Enliven Therapeutics Inc
ELVN
|
BUY |
$65.00
Est. +28%
|
$50.80 | $62.32 |
Pending
|
$47.25
-7.0%
|
| Jul 07, 2026 |
Telix Pharmaceuticals Limited
TLPPF
|
BUY |
$20.00
Est. +75%
|
$11.45 | $10.95 |
Pending
|
$8.95
-21.8%
|
| Jul 02, 2026 |
Exelixis Inc
EXEL
|
BUY |
$56.00
Est. +4%
|
$53.96 | $73.44 |
Target Met
|
$72.75
+34.8%
|
| Jun 02, 2026 |
Akoustis Technologies Inc
AKTS
|
BUY |
$35.00
Est. +78%
|
$19.61 | $34.19 |
Precision Hit (±3%)
|
$15.20
-22.5%
|
| May 22, 2026 |
Immix Biopharma Inc
IMMX
|
BUY |
$20.00
Est. +124%
|
$8.92 | $15.10 |
Pending
|
$7.97
-10.7%
|
| May 06, 2026 |
Cogent Biosciences Inc
COGT
|
BUY |
$55.00
Est. +49%
|
$36.98 | $43.39 |
Pending
|
$31.49
-14.8%
|
| Apr 28, 2026 |
Cullinan Therapeutics Inc
CGEM
|
BUY |
$30.00
Est. +135%
|
$12.79 | $23.19 |
Pending
|
$12.49
-2.3%
|
| Apr 14, 2026 |
Revolution Medicines Inc
RVMD
|
BUY |
$169.00
Est. +24%
|
$136.30 | $224.31 |
Target Met
|
$199.70
+46.5%
|
| Mar 13, 2026 |
Elicio Therapeutics Inc.
ELTX
|
BUY |
$17.00
Est. +56%
|
$10.90 | $16.00 |
Pending
|
$1.56
-85.7%
|
| Feb 24, 2026 |
ORIC Pharmaceuticals Inc
ORIC
|
BUY |
$25.00
Est. +88%
|
$13.27 | $14.52 |
Pending
|
$9.34
-29.6%
|
| Jan 08, 2026 |
Exelixis Inc
EXEL
|
BUY |
$52.00
Est. +16%
|
$44.79 | $73.44 |
Target Met
|
$72.75
+62.4%
|
| Dec 10, 2025 |
Nurix Therapeutics Inc
NRIX
|
BUY |
$31.00
Est. +59%
|
$19.55 | $27.99 |
Pending
|
$15.95
-18.4%
|
| Dec 01, 2025 |
Nuvation Bio Inc - Ordinary Shares - Class A
NUVB
|
BUY |
$10.00
Est. +24%
|
$8.04 | $9.75 |
Precision Hit (±3%)
|
$4.73
-41.2%
|
| Nov 05, 2025 |
Exelixis Inc
EXEL
|
BUY |
$49.00
Est. +21%
|
$40.52 | $73.44 |
Target Met
|
$72.75
+79.5%
|
| Oct 14, 2025 |
Zymeworks BC Inc
ZYME
|
BUY |
$26.00
Est. +44%
|
$18.11 | $31.21 |
Target Met
|
$30.94
+70.8%
|
| Oct 13, 2025 |
Karyopharm Therapeutics Inc
KPTI
|
BUY |
$15.00
Est. +173%
|
$5.50 | $10.99 |
Miss
|
$0.08
-98.5%
|
| Sep 15, 2025 |
BridgeBio Oncology Therapeutics Inc.
BBOT
|
BUY |
$27.00
Est. +177%
|
$9.73 | - | - |
$2.30
-76.4%
|
| Sep 10, 2025 |
Telix Pharmaceuticals Limited
TLX
|
BUY |
$20.00
Est. +106%
|
$9.69 | - | - |
$9.67
-0.2%
|
| Aug 22, 2025 |
Bicara Therapeutics Inc. Common Stock
BCAX
|
BUY |
$40.00
Est. +238%
|
$11.84 | $30.93 |
Miss
|
$8.89
-24.9%
|
| Aug 12, 2025 |
Exelixis Inc
EXEL
|
BUY |
$46.00
Est. +23%
|
$37.41 | $57.57 |
Target Met
|
$72.75
+94.5%
|
| May 14, 2025 |
Revolution Medicines Inc
RVMD
|
BUY |
$72.00
Est. +72%
|
$41.88 | $155.70 |
Target Met
|
$199.70
+376.8%
|
| May 14, 2025 |
BioNTech SE - ADR
BNTX
|
BUY |
$134.00
Est. +38%
|
$97.27 | $124.00 |
Miss
|
$90.70
-6.8%
|
| Jan 14, 2025 |
Cogent Biosciences Inc
COGT
|
BUY |
$14.00
Est. +70%
|
$8.25 | $43.73 |
Target Met
|
$31.49
+281.7%
|
| Jan 10, 2025 |
Exelixis Inc
EXEL
|
BUY |
$40.00
Est. +11%
|
$36.02 | $49.40 |
Target Met
|
$72.75
+102.0%
|
| Oct 21, 2024 |
Nurix Therapeutics Inc
NRIX
|
BUY |
$30.00
Est. +19%
|
$25.19 | $29.56 |
Precision Hit (±3%)
|
$15.95
-36.7%
|
| Sep 25, 2024 |
Zymeworks BC Inc
ZYME
|
SELL |
$12.00
Est. +4%
|
$12.50 | $9.04 (Low) |
Target Met
|
$30.94
-147.5%
|
| Sep 16, 2024 |
Relay Therapeutics Inc
RLAY
|
BUY |
$19.00
Est. +150%
|
$7.60 | $8.32 |
Miss
|
$18.01
+137.0%
|
| Sep 16, 2024 |
Nuvation Bio Inc - Ordinary Shares - Class A
NUVB
|
BUY |
$7.00
Est. +130%
|
$3.05 | $4.09 |
Miss
|
$4.73
+54.9%
|
| Sep 10, 2024 |
Prelude Therapeutics Inc
PRLD
|
SELL |
$5.00
Est. +3%
|
$5.17 | $0.61 (Low) |
Target Met
|
$4.08
+21.1%
|
| Sep 10, 2024 |
ArriVent BioPharma Inc.
AVBP
|
BUY |
$36.00
Est. +28%
|
$28.04 | $36.20 |
Bullseye Hit (±1%)
|
$13.49
-51.9%
|
| Sep 04, 2024 |
Repare Therapeutics Inc
RPTX
|
BUY |
$10.00
Est. +256%
|
$2.81 | $4.07 |
Miss
|
$2.65
-5.7%
|
| Sep 03, 2024 |
Cogent Biosciences Inc
COGT
|
BUY |
$17.00
Est. +50%
|
$11.37 | $13.50 |
Miss
|
$31.49
+177.0%
|
| Aug 16, 2024 |
ArriVent BioPharma Inc.
AVBP
|
BUY |
$30.00
Est. +27%
|
$23.62 | $36.20 |
Target Met
|
$13.49
-42.9%
|
| Aug 08, 2024 |
SpringWorks Therapeutics Inc
SWTX
|
BUY |
$76.00
Est. +124%
|
$33.93 | $61.57 |
Miss
|
$46.99
+38.5%
|
| Aug 08, 2024 |
Exelixis Inc
EXEL
|
BUY |
$29.00
Est. +9%
|
$26.52 | $49.40 |
Target Met
|
$72.75
+174.3%
|
| Jul 01, 2024 |
Immix Biopharma Inc
IMMX
|
BUY |
$7.00
Est. +254%
|
$1.98 | $3.00 |
Miss
|
$7.97
+302.5%
|
| Jun 18, 2024 |
Nurix Therapeutics Inc
NRIX
|
BUY |
$26.00
Est. +41%
|
$18.44 | $29.56 |
Target Met
|
$15.95
-13.5%
|
| Jun 07, 2024 |
Replimune Group Inc
REPL
|
BUY |
$17.00
Est. +139%
|
$7.11 | $16.55 |
Precision Hit (±3%)
|
$20.69
+191.0%
|
| May 28, 2024 |
Tango Therapeutics Inc
TNGX
|
BUY |
$13.00
Est. +88%
|
$6.91 | $12.02 |
Miss
|
$23.18
+235.5%
|
| May 16, 2024 |
Black Diamond Therapeutics Inc
BDTX
|
BUY |
$11.00
Est. +102%
|
$5.44 | $6.75 |
Miss
|
$1.90
-65.1%
|
| May 10, 2024 |
Y-Mabs Therapeutics Inc
YMAB
|
BUY |
$22.00
Est. +71%
|
$12.87 | $16.10 |
Miss
|
$8.61
-33.1%
|
| May 07, 2024 |
Adc Therapeutics SA
ADCT
|
BUY |
$8.00
Est. +80%
|
$4.45 | $4.13 |
Miss
|
$1.72
-61.5%
|
| May 03, 2024 |
Kronos Bio Inc
KRON
|
BUY |
$2.25
Est. +118%
|
$1.03 | $1.59 |
Miss
|
$0.88
-14.6%
|
| Mar 28, 2024 |
Nuvation Bio Inc - Ordinary Shares - Class A
NUVB
|
BUY |
$8.00
Est. +102%
|
$3.97 | $3.96 |
Miss
|
$4.73
+19.0%
|
| Mar 21, 2024 |
ORIC Pharmaceuticals Inc
ORIC
|
BUY |
$21.00
Est. +44%
|
$14.59 | $14.66 |
Miss
|
$9.34
-36.0%
|
| Mar 21, 2024 |
Calidi Biotherapeutics Inc - Ordinary Shares - Class A
CLDI
|
BUY |
$2.00
Est. +233%
|
$0.60 | $1,593.60 |
Target Met
|
$0.75
+25.0%
|
| Nov 01, 2022 |
Zymeworks BC Inc
ZYME
|
BUY |
$8.00
Est. +10%
|
$7.30 | - | - |
$30.94
+323.8%
|
| Apr 16, 2022 |
BioNTech SE - ADR
BNTX
|
BUY |
$298.00
Est. +70%
|
$175.29 | - | - |
$90.70
-48.3%
|
| Sep 20, 2021 |
Zymeworks BC Inc
ZYME
|
BUY |
$44.00
Est. +33%
|
$33.07 | - | - |
$30.94
-6.4%
|
Parabilis Medicines, Inc.
PBLS
Oct 22, 2026
Signal & Target
BUY
$40.00
Start Price
$27.85
Best Price (1Y)
$30.83
Current Price
$30.36
Return
+9.0%
ArriVent BioPharma Inc.
AVBP
Oct 08, 2026
Signal & Target
BUY
$27.00
Start Price
$16.89
Best Price (1Y)
$21.22
Current Price
$13.49
Return
-20.1%
Adicet Bio Inc
ACET
Sep 21, 2026
Signal & Target
BUY
$27.00
Start Price
$9.18
Best Price (1Y)
$9.39
Current Price
$3.10
Return
-66.2%
BlossomHill Therapeutics, Inc.
BLSM
Sep 01, 2026
Signal & Target
BUY
$35.00
Start Price
$18.30
Best Price (1Y)
$18.22
Current Price
$12.38
Return
-32.3%
Revolution Medicines Inc
RVMD
Aug 27, 2026
Signal & Target
BUY
$280.00
Start Price
$215.44
Best Price (1Y)
$224.31
Current Price
$199.70
Return
-7.3%
Tango Therapeutics Inc
TNGX
Aug 18, 2026
Signal & Target
BUY
$68.00
Start Price
$25.29
Best Price (1Y)
$27.97
Current Price
$23.18
Return
-8.3%
ORIC Pharmaceuticals Inc
ORIC
Aug 10, 2026
Signal & Target
BUY
$27.00
Start Price
$13.50
Best Price (1Y)
$14.52
Current Price
$9.34
Return
-30.8%
Immix Biopharma Inc
IMMX
Aug 10, 2026
Signal & Target
BUY
$25.00
Start Price
$9.72
Best Price (1Y)
$15.10
Current Price
$7.97
Return
-18.0%
Karyopharm Therapeutics Inc
KPTI
Jul 31, 2026
Signal & Target
SELL
$3.00
Start Price
$7.01
Best Price (1Y)
$0.08
Current Price
$0.08
Return
+98.8%
Enliven Therapeutics Inc
ELVN
Jul 09, 2026
Signal & Target
BUY
$65.00
Start Price
$50.80
Best Price (1Y)
$62.32
Current Price
$47.25
Return
-7.0%
Telix Pharmaceuticals Limited
TLPPF
Jul 07, 2026
Signal & Target
BUY
$20.00
Start Price
$11.45
Best Price (1Y)
$10.95
Current Price
$8.95
Return
-21.8%
Exelixis Inc
EXEL
Jul 02, 2026
Signal & Target
BUY
$56.00
Start Price
$53.96
Best Price (1Y)
$73.44
Current Price
$72.75
Return
+34.8%
Akoustis Technologies Inc
AKTS
Jun 02, 2026
Signal & Target
BUY
$35.00
Start Price
$19.61
Best Price (1Y)
$34.19
Current Price
$15.20
Return
-22.5%
Immix Biopharma Inc
IMMX
May 22, 2026
Signal & Target
BUY
$20.00
Start Price
$8.92
Best Price (1Y)
$15.10
Current Price
$7.97
Return
-10.7%
Cogent Biosciences Inc
COGT
May 06, 2026
Signal & Target
BUY
$55.00
Start Price
$36.98
Best Price (1Y)
$43.39
Current Price
$31.49
Return
-14.8%
Cullinan Therapeutics Inc
CGEM
Apr 28, 2026
Signal & Target
BUY
$30.00
Start Price
$12.79
Best Price (1Y)
$23.19
Current Price
$12.49
Return
-2.3%
Revolution Medicines Inc
RVMD
Apr 14, 2026
Signal & Target
BUY
$169.00
Start Price
$136.30
Best Price (1Y)
$224.31
Current Price
$199.70
Return
+46.5%
Elicio Therapeutics Inc.
ELTX
Mar 13, 2026
Signal & Target
BUY
$17.00
Start Price
$10.90
Best Price (1Y)
$16.00
Current Price
$1.56
Return
-85.7%
ORIC Pharmaceuticals Inc
ORIC
Feb 24, 2026
Signal & Target
BUY
$25.00
Start Price
$13.27
Best Price (1Y)
$14.52
Current Price
$9.34
Return
-29.6%
Exelixis Inc
EXEL
Jan 08, 2026
Signal & Target
BUY
$52.00
Start Price
$44.79
Best Price (1Y)
$73.44
Current Price
$72.75
Return
+62.4%
Nurix Therapeutics Inc
NRIX
Dec 10, 2025
Signal & Target
BUY
$31.00
Start Price
$19.55
Best Price (1Y)
$27.99
Current Price
$15.95
Return
-18.4%
Nuvation Bio Inc - Ordinary Shares - Class A
NUVB
Dec 01, 2025
Signal & Target
BUY
$10.00
Start Price
$8.04
Best Price (1Y)
$9.75
Current Price
$4.73
Return
-41.2%
Exelixis Inc
EXEL
Nov 05, 2025
Signal & Target
BUY
$49.00
Start Price
$40.52
Best Price (1Y)
$73.44
Current Price
$72.75
Return
+79.5%
Zymeworks BC Inc
ZYME
Oct 14, 2025
Signal & Target
BUY
$26.00
Start Price
$18.11
Best Price (1Y)
$31.21
Current Price
$30.94
Return
+70.8%
Karyopharm Therapeutics Inc
KPTI
Oct 13, 2025
Signal & Target
BUY
$15.00
Start Price
$5.50
Best Price (1Y)
$10.99
Current Price
$0.08
Return
-98.5%
BridgeBio Oncology Therapeutics Inc.
BBOT
Sep 15, 2025
Signal & Target
BUY
$27.00
Start Price
$9.73
Best Price (1Y)
-
Current Price
$2.30
Return
-76.4%
Telix Pharmaceuticals Limited
TLX
Sep 10, 2025
Signal & Target
BUY
$20.00
Start Price
$9.69
Best Price (1Y)
-
Current Price
$9.67
Return
-0.2%
Bicara Therapeutics Inc. Common Stock
BCAX
Aug 22, 2025
Signal & Target
BUY
$40.00
Start Price
$11.84
Best Price (1Y)
$30.93
Current Price
$8.89
Return
-24.9%
Exelixis Inc
EXEL
Aug 12, 2025
Signal & Target
BUY
$46.00
Start Price
$37.41
Best Price (1Y)
$57.57
Current Price
$72.75
Return
+94.5%
Revolution Medicines Inc
RVMD
May 14, 2025
Signal & Target
BUY
$72.00
Start Price
$41.88
Best Price (1Y)
$155.70
Current Price
$199.70
Return
+376.8%
BioNTech SE - ADR
BNTX
May 14, 2025
Signal & Target
BUY
$134.00
Start Price
$97.27
Best Price (1Y)
$124.00
Current Price
$90.70
Return
-6.8%
Cogent Biosciences Inc
COGT
Jan 14, 2025
Signal & Target
BUY
$14.00
Start Price
$8.25
Best Price (1Y)
$43.73
Current Price
$31.49
Return
+281.7%
Exelixis Inc
EXEL
Jan 10, 2025
Signal & Target
BUY
$40.00
Start Price
$36.02
Best Price (1Y)
$49.40
Current Price
$72.75
Return
+102.0%
Nurix Therapeutics Inc
NRIX
Oct 21, 2024
Signal & Target
BUY
$30.00
Start Price
$25.19
Best Price (1Y)
$29.56
Current Price
$15.95
Return
-36.7%
Zymeworks BC Inc
ZYME
Sep 25, 2024
Signal & Target
SELL
$12.00
Start Price
$12.50
Best Price (1Y)
$9.04
Current Price
$30.94
Return
-147.5%
Relay Therapeutics Inc
RLAY
Sep 16, 2024
Signal & Target
BUY
$19.00
Start Price
$7.60
Best Price (1Y)
$8.32
Current Price
$18.01
Return
+137.0%
Nuvation Bio Inc - Ordinary Shares - Class A
NUVB
Sep 16, 2024
Signal & Target
BUY
$7.00
Start Price
$3.05
Best Price (1Y)
$4.09
Current Price
$4.73
Return
+54.9%
Prelude Therapeutics Inc
PRLD
Sep 10, 2024
Signal & Target
SELL
$5.00
Start Price
$5.17
Best Price (1Y)
$0.61
Current Price
$4.08
Return
+21.1%
ArriVent BioPharma Inc.
AVBP
Sep 10, 2024
Signal & Target
BUY
$36.00
Start Price
$28.04
Best Price (1Y)
$36.20
Current Price
$13.49
Return
-51.9%
Repare Therapeutics Inc
RPTX
Sep 04, 2024
Signal & Target
BUY
$10.00
Start Price
$2.81
Best Price (1Y)
$4.07
Current Price
$2.65
Return
-5.7%
Cogent Biosciences Inc
COGT
Sep 03, 2024
Signal & Target
BUY
$17.00
Start Price
$11.37
Best Price (1Y)
$13.50
Current Price
$31.49
Return
+177.0%
ArriVent BioPharma Inc.
AVBP
Aug 16, 2024
Signal & Target
BUY
$30.00
Start Price
$23.62
Best Price (1Y)
$36.20
Current Price
$13.49
Return
-42.9%
SpringWorks Therapeutics Inc
SWTX
Aug 08, 2024
Signal & Target
BUY
$76.00
Start Price
$33.93
Best Price (1Y)
$61.57
Current Price
$46.99
Return
+38.5%
Exelixis Inc
EXEL
Aug 08, 2024
Signal & Target
BUY
$29.00
Start Price
$26.52
Best Price (1Y)
$49.40
Current Price
$72.75
Return
+174.3%
Immix Biopharma Inc
IMMX
Jul 01, 2024
Signal & Target
BUY
$7.00
Start Price
$1.98
Best Price (1Y)
$3.00
Current Price
$7.97
Return
+302.5%
Nurix Therapeutics Inc
NRIX
Jun 18, 2024
Signal & Target
BUY
$26.00
Start Price
$18.44
Best Price (1Y)
$29.56
Current Price
$15.95
Return
-13.5%
Replimune Group Inc
REPL
Jun 07, 2024
Signal & Target
BUY
$17.00
Start Price
$7.11
Best Price (1Y)
$16.55
Current Price
$20.69
Return
+191.0%
Tango Therapeutics Inc
TNGX
May 28, 2024
Signal & Target
BUY
$13.00
Start Price
$6.91
Best Price (1Y)
$12.02
Current Price
$23.18
Return
+235.5%
Black Diamond Therapeutics Inc
BDTX
May 16, 2024
Signal & Target
BUY
$11.00
Start Price
$5.44
Best Price (1Y)
$6.75
Current Price
$1.90
Return
-65.1%
Y-Mabs Therapeutics Inc
YMAB
May 10, 2024
Signal & Target
BUY
$22.00
Start Price
$12.87
Best Price (1Y)
$16.10
Current Price
$8.61
Return
-33.1%
Adc Therapeutics SA
ADCT
May 07, 2024
Signal & Target
BUY
$8.00
Start Price
$4.45
Best Price (1Y)
$4.13
Current Price
$1.72
Return
-61.5%
Kronos Bio Inc
KRON
May 03, 2024
Signal & Target
BUY
$2.25
Start Price
$1.03
Best Price (1Y)
$1.59
Current Price
$0.88
Return
-14.6%
Nuvation Bio Inc - Ordinary Shares - Class A
NUVB
Mar 28, 2024
Signal & Target
BUY
$8.00
Start Price
$3.97
Best Price (1Y)
$3.96
Current Price
$4.73
Return
+19.0%
ORIC Pharmaceuticals Inc
ORIC
Mar 21, 2024
Signal & Target
BUY
$21.00
Start Price
$14.59
Best Price (1Y)
$14.66
Current Price
$9.34
Return
-36.0%
Signal & Target
BUY
$2.00
Start Price
$0.60
Best Price (1Y)
$1,593.60
Current Price
$0.75
Return
+25.0%
Zymeworks BC Inc
ZYME
Nov 01, 2022
Signal & Target
BUY
$8.00
Start Price
$7.30
Best Price (1Y)
-
Current Price
$30.94
Return
+323.8%
BioNTech SE - ADR
BNTX
Apr 16, 2022
Signal & Target
BUY
$298.00
Start Price
$175.29
Best Price (1Y)
-
Current Price
$90.70
Return
-48.3%
Zymeworks BC Inc
ZYME
Sep 20, 2021
Signal & Target
BUY
$44.00
Start Price
$33.07
Best Price (1Y)
-
Current Price
$30.94
Return
-6.4%